Attenuation of Hyperlipidemia by Medicinal Formulations of Emblica officinalis Synergized with Nanotechnological Approaches.

Rachitha, P. and Krupashree, K. and Renal Antoinette, Lazar and Vijai Kumar, Gupta and Baskaran, Stephen Inbaraj (2023) Attenuation of Hyperlipidemia by Medicinal Formulations of Emblica officinalis Synergized with Nanotechnological Approaches. Bioengineering, 10. p. 64.

PDF bioengineering-10-00064-v2.pdf - Published Version Restricted to Registered users only Download (2MB) | Request a copy

Abstract

The ayurvedic herb Emblica officinalis (E. officinalis) is a gift to mankind to acquire a healthy lifestyle. It has great therapeutic and nutritional importance. Emblica officinalis, also known as Indian gooseberry or Amla, is a member of the Euphorbiaceae family. Amla is beneficial for treating illnesses in all its forms. The most crucial component is a fruit, which is also the most common. It is used frequently in Indian medicine as a restorative, diuretic, liver tonic, refrigerant, stomachic, laxative, antipyretic, hair tonic, ulcer preventive, and for the common cold and fever. Hyperlipidemia is also known as high cholesterol or an increase in one or more lipid-containing blood proteins. Various phy�tocompounds, including polyphenols, vitamins, amino acids, fixed oils, and flavonoids, are present in the various parts of E. officinalis. E. officinalis has been linked to a variety of pharmacological effects in earlier studies, including hepatoprotective, immunomodulatory, antimicrobial, radioprotective, and hyperlipidemic effects. The amla-derived active ingredients and food products nevertheless encounter challenges such as instability and interactions with other food matrices. Considering the issue from this perspective, food component nanoencapsulation is a young and cutting-edge field for controlled and targeted delivery with a range of preventative activities. The nanoformulation of E. officinalis facilitates the release of active components or food ingredients, increased bioaccessibility, enhanced therapeutic activities, and digestion in the human body. Accordingly, the current review provides a summary of the phytoconstituents of E. officinalis, pharmacological actions detailing the plant E. officinalis’s traditional uses, and especially hyperlipidemic activity. Correspondingly, the article describes the uses of nanotechnology in amla therapeutics and functional ingredients.

Item Type:	Article
Uncontrolled Keywords:	Emblica officinalis; phytochemicals; hyperlipidemia; pharmacology; nanoformulation
Subjects:	600 Technology > 01 Medical sciences > 15 Pharmacology 600 Technology > 03 Agriculture > 04 Medicinal Plants 600 Technology > 08 Food technology > 24 Fruits > 03 Citrus fruits
Divisions:	Dept. of Biochemistry
Depositing User:	Food Sci. & Technol. Information Services
Date Deposited:	26 May 2023 04:06
Last Modified:	26 May 2023 04:06
URI:	http://ir.cftri.res.in/id/eprint/16472

Actions (login required)

View Item